r2rtf
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
A side-by-side editorial comparison of CRediTas and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.
A CRediT author-statement generator that renamed itself, then went quiet for two years.
CRediTas turns a contributor-roles table into a CRediT Author Statement for a paper. The 0.2.0 release in April 2023 did the heavy lifting — package rename, a full object_verb() API rename, and output that drops straight into R Markdown or Quarto. The 0.3.0 release in August 2025 is the only activity since and carries no changelog text beyond a pointer to NEWS.md.
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
CRediTas turns a contributor-roles table into a CRediT Author Statement for a paper. The 0.2.0 release in April 2023 did the heavy lifting — package rename, a full object_verb() API rename, and output that drops straight into R Markdown or Quarto. The 0.3.0 release in August 2025 is the only activity since and carries no changelog text beyond a pointer to NEWS.md.
Development front-loaded a breaking cleanup during rOpenSci review and has coasted since. The design bet made in 0.2.0 — return a string for inline use rather than write a file — pointed the package at literate authoring workflows rather than at standalone scripts, and nothing since has moved away from it. The empty 0.3.0 note makes the current direction impossible to read from the feed.
Too little is published to call the next move; the 0.3.0 entry would need to carry its actual changes for the trajectory to be readable from the changelog at all.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either CRediTas or pharmaverseadam.
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
crul took mocking back from webmockr and made it a property of the client itself
Six releases, six identical bodies — the feed carries the package abstract instead of release notes
chattr deleted every LLM integration it had written and outsourced the lot to ellmer
See all CRediTas alternatives → · See all pharmaverseadam alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. CRediTas and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. CRediTas and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top CRediTas alternatives in Analytics are ranked by recent ship velocity. Browse the "CRediTas alternatives" section above for the current picks, or visit /alternatives/creditas for the full list with editorial commentary on each.
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.